Saliva is superior over nasopharyngeal swab for detecting SARS-CoV2 in COVID-19 patients

Scaling up of diagnostic capacity is needed to mitigate the global pandemic of SARS-CoV2. However, there are challenges including shortage of sample collection swabs and transport medium. Saliva has been recommended as a simple, low-cost, non-invasive option. However, data from different populations...

Descripción completa

Detalles Bibliográficos
Autores principales: Beyene, Getachew Tesfaye, Alemu, Fekadu, Kebede, Eyerusalem Solomon, Alemayehu, Dawit Hailu, Seyoum, Tamirayehu, Tefera, Dessalegn Abeje, Assefa, Gebeyehu, Tesfaye, Abebech, Habte, Anteneh, Bedada, Gadissa, Tegene, Birhanemeskel, Yeshambaw, Melese, Wassie, Liya, Mihret, Adane, Abdissa, Alemseged, Mulu, Andargachew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608806/
https://www.ncbi.nlm.nih.gov/pubmed/34811429
http://dx.doi.org/10.1038/s41598-021-02097-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608806/
https://www.ncbi.nlm.nih.gov/pubmed/34811429
http://dx.doi.org/10.1038/s41598-021-02097-2

Ejemplares similares